Frequently bought together
Phase 2 trial data (NEJM, 2023) showed substantial MRI-PDFF-measured liver fat reductions at 8 mg and 12 mg weekly doses, with some participants falling below the 5% hepatic steatosis threshold
GLP1-RA: glucagon-like peptide-1 receptor agonist
EASY-TO-TAKE liquid drops - No more hard-to-swallow pills or capsules
Eureka Technical Q&A breaks down how peptide therapy works, its health benefits, and its growing use in areas like anti-aging, muscle recovery, and immune supporthelping you understand its potential in modern medicine
So things like diet, nutrition, environmental exposures, these all sort of degrade our body over time